Breathe Well Live Well
Condition: Asthma
Interventions: Drug: dupilumab SAR231893/REGN668; Drug: placebo; Drug: fluticasone propionate and salmeterol; Drug: budesonide and formoterol; Drug: mometasone furoate and formoterol
Sponsors: Sanofi; Regeneron Pharmaceuticals
Not yet recruiting – verified October 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: Dupilumab SAR231893 (REGN668); Drug: Placebo; Drug: asthma controller therapies (including prednisone/prednisolone)
Sponsors: Sanofi; Regeneron Pharmaceuticals
Not yet recruiting – verified August 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Healthy
Interventions: Other: 10l/min; Other: 30l/min; Other: 50l/min
Sponsor: Universidade Federal de Pernambuco
Recruiting – verified August 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Behavioral: 2: Intervention; Behavioral: 1: Control
Sponsor: Assistance Publique – Hôpitaux de Paris
Not yet recruiting – verified April 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: dupilumab SAR231893 (REGN668); Drug: placebo
Sponsors: Sanofi; Regeneron Pharmaceuticals
Not yet recruiting – verified April 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Intervention: Drug: OC000459
Sponsors: Atopix Therapeutics, Ltd.; Simbec Research
Not yet recruiting – verified January 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: A006 DPI; Drug: A006 DPI; Drug: Proventil® MDI; Drug: Proventil® MDI
Sponsor: Amphastar Pharmaceuticals, Inc.
Active, not recruiting – verified October 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: Placebo; Drug: PF-03715455
Sponsor: Pfizer
Not yet recruiting – verified August 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: A006 DPI; Drug: A006 DPI; Other: Placebo DPI; Drug: Proventil® MDI; Drug: Proventil® MDI
Sponsor: Amphastar Pharmaceuticals, Inc.
Recruiting – verified August 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
 |
Related Articles |
Blinded sensory evaluation of extensively hydrolyzed formulas and amino acid formulas.
Ann Allergy Asthma Immunol. 2014 Jun 24;
Authors: de Jong NW, Sprikkelman AB, Oude Elberink HN, Arends NJ, Vlieg-Boerstra BJ
PMID: 24973273 [PubMed – as supplied by publisher]
View full post on pubmed: asthma